Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on May 22, 2025
Rapid7 to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 22, 2025
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will be attending the following conferences: The William Blair 45th Annual Growth Stock Conference in …
Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 22, 2025
WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models …
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 22, 2025
MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the 2025 …
Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
GlobeNewswire
·
May 22, 2025
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that it has commenced an underwritten public offering of shares of its …
Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
GlobeNewswire
·
May 22, 2025
Immix Biopharma today reported ASCO abstract results from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201 demonstrating strong efficacy and favorable safety. – NXC-201 demonstrated a complete response (CR) rate of 71% (5/7 patients) – …
Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire
·
May 22, 2025
ISELIN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced an …
Intchains Group Limited Reports First Quarter 2025 Unaudited Financial Results
GlobeNewswire
·
May 22, 2025
Total revenues of US$18.2 million exceeds guidance, up 445.5% YoY Total ETH-based cryptocurrency units were approximately 7,023, up 23.2% QoQ Income from operations reach US$5.1 million, achieving turnaround from prior-year period SINGAPORE, May 22, 2025 ( …
Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China
GlobeNewswire
·
May 22, 2025
Achieved statistically significant ≥1-stage fibrosis regression at Week 52 vs. placebo (52.85% vs. 29.84%, P=0.0002). Demonstrated favorable safety and tolerability profile: 4.88% serious adverse events vs. 6.45% for placebo; zero discontinuations due to …
IPG Photonics Appoints Mira Sahney as Senior Vice President of Global Laser Systems
GlobeNewswire
·
May 22, 2025
MARLBOROUGH, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP), the global leader in high-performance fiber lasers and laser systems, announced the appointment of Mira Sahney as Senior Vice President, Global Laser Systems. …
Skywork.ai Launches Globally, Introducing the World’s First DeepResearch-Powered Workspace Super Agents
GlobeNewswire
·
May 22, 2025
Singapore , May 22, 2025 (GLOBE NEWSWIRE) -- In May 2025, Skywork.ai officially entered the global stage, launching the world’s first AI Office Suite powered by DeepResearch technology, with full support for both English and Japanese to enhance …
PESG Research Report: A Review of Silexion Therapeutics' Innovative KRAS-Driven Cancer Treatment
GlobeNewswire
·
May 22, 2025
New York, May 22, 2025 (GLOBE NEWSWIRE) -- PESG Research today announced the release of a report examining Silexion Therapeutics, an innovative biotechnology company developing unique RNA interference (RNAi) therapies targeting KRAS-driven cancers. The …
Citrin Foundation and University Children’s Hospital Zürich Launch First Center for Translational Research in UCD
EIN Presswire
·
May 22, 2025
Pioneering translational model combines cutting-edge science, clinical leadership, global collaboration, and a patient-first mission to unlock new therapies LONDON, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- The Citrin Foundation and the …
Houston Emerges as Global Center for Brain Health Innovation
GlobeNewswire
·
May 22, 2025
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Protecting and enriching human brain health and performance may be one of the most important economic strategies that businesses and governments pursue as they seek to strengthen workforces, mitigate the surging …
Endurance Bio Inc. Announces Selection of T-168 for Neuro-SysMed’s SLEIPNIR Platform Trial in Parkinson’s Disease
GlobeNewswire
·
May 22, 2025
SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Endurance Bio Inc., a clinical-stage biotechnology company developing therapies for neurodegenerative and metabolic diseases, today announced that its compound, T-168, has been selected for testing on …
Creative Biolabs Introduces Game-Changing CRISPR Solutions for Accelerated Gene Therapy Development
EIN Presswire
·
May 22, 2025
By leveraging the potential of CRISPR gene editing technology, Creative Biolabs provides custom gene therapy development solutions to accelerate your research. SHIRLEY, NY, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The gene therapy landscape has …
CSGO Betting Sites: Thunderpick Named the Top U.S. Sportsbook for Counter-Strike: Global Offensive
GlobeNewswire
·
May 22, 2025
New York City, May 22, 2025 (GLOBE NEWSWIRE) -- Thunderpick has redefined the CSGO betting experience for players across the U.S., offering everything a serious bettor could want in one streamlined platform. With competitive odds, real-time match coverage, …
Newly Formed National Alliance Aims to Help Cities and States Combat Opioid Crisis and Improve Public Health Outcomes
GlobeNewswire
·
May 22, 2025
Milwaukee, Wis., May 22, 2025 (GLOBE NEWSWIRE) -- In a timely effort to address the nation’s opioid epidemic, CMRignite, one of the nation’s leading cause marketing agencies, has launched a new national recovery alliance composed of trusted messengers, …
Celebrating 10 Years of National Deafblind Awareness Month in Canada
GlobeNewswire
·
May 22, 2025
Newmarket, Ontario, Canada, May 22, 2025 (GLOBE NEWSWIRE) -- June 2025 marks a significant milestone—10 years since the Senate of Canada officially proclaimed June as National Deafblind Awareness Month. This anniversary is a powerful opportunity to …
Best Sportsbook Promos: SportsBetting.ag Picked as the Top US Site for Sports Betting Bonuses
GlobeNewswire
·
May 22, 2025
Belize City, May 22, 2025 (GLOBE NEWSWIRE) -- When it comes to finding the best sportsbook promos site for US players, SportsBetting.ag stands out for one simple reason: it offers more value, more often. From generous sign-up bonuses to ongoing reloads and …
Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older
GlobeNewswire
·
May 22, 2025
Once-daily ZORYVE foam provides powerful clearance and rapid itch relief from head to toe with no limitation on duration of use More than half of the nearly 9 million people in the United States with plaque psoriasis experience scalp involvement Healthcare …